ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

Clinical trial NCT00819351 · COMPLETED

Trial details

NCT number: NCT00819351
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2009-01-01
Primary completion: 2016-03-02
Enrollment: 650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.